Registered User Login
Research Journal of Pharmaceutical Dosage Forms and Technology
ISSN: 0975-4377(Online), 0975-234X(Print)
News & Conferences
Volume No. :
Issue No. :
ISSN Print :
ISSN Online :
Click to Login
Formulation and Evaluation of Combinational Capsule of Metoprolol Succinate and Atorvastatin Calcium
T. Neelima Rani
N.K. Durga Devi
A. Prameela Rani
T. Neelima Rani, N.K. Durga Devi*, A. Prameela Rani, B.R. Madhavi and B.S. Mrudula
KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada-10.
Hypertensive patients commonly exhibit lipid abnormalities and frequently require statins in combination with the antihypertensive therapy. So, an attempt has been made to formulate the Metoprolol succinate extended release and Atorvastatin calcium combinational capsules. Metoprolol succinate is the cardio-selective ß-adrenoreceptor blocking agent used to treat hypertension. Atorvastatin is a synthetic lipid lowering agent and it is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A(HMG-COA) reductase. To match the release pattern of the Atorvastatin calcium with the theoretical release profiles different formulation trials were under taken. Among all the six formulations, the release profile of trial F-6 was found to be similar to the theoretical release profiles. The capsules were evaluated for uniformity of weight, locking length, assay, water content and content uniformity.
T. Neelima Rani, N.K. Durga Devi, A. Prameela Rani, B.R. Madhavi , B.S. Mrudula. Formulation and Evaluation of Combinational Capsule of Metoprolol Succinate and Atorvastatin Calcium. Research J. Pharma. Dosage Forms and Tech. 2010; 2(3): 255-260.
Visitor's No. :